https://orcid.org/0000-0003-1155-6306
References
- Adewoyin AS. Management of sickle cell disease: a review for physician education in Nigeria (Sub-Saharan Africa). Anemia. 2015;2015:791498.
- Moez P, Younan DNA. High prevalence of haemoglobin S in the closed Egyptian community of Siwa Oasis. J Clin Pathol. 2016;69(7):632–636.
- Rodrigues DLG, Adegoke SA, de Campos RSM, et al. Patients with sickle cell disease are frequently excluded from the benefits of transcranial doppler screening for the risk of stroke despite extensive and compelling evidence. Arq Neuro-Psiquiatr. 2017;75(1):15–19.
- Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5–11.
- Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest. 2007;117(4):850–858.
- Al-Naama LM, Hassan MK, Mehdi JK. Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia. Qatar Med J. 2015;2015(2):14.
- De Montalembert M, Brousse V, Kossorotoff M. How I manage cerebral vasculopathy in children with sickle cell disease. Br J Haematol. 2015;170(5):615–625.
- Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–2236.
- Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol. 2012;87(8):795–803.
- Steinberg MH, Chui DHK, Dover GJ, et al. Fetal hemoglobin in sickle cell anemia: a glass half full. Blood. 2014;123(4):481–485.
- Meier ER, Fasano RM, Estrada M, et al. Early reticulocytosis and anemia are associated with abnormal and conditional transcranial Doppler in children with sickle cell anemia. J Pediatr. 2016;169:227–231.e1.